HVNTID's [Regulatives / Guidelines]

posted by d_labes  – Berlin, Germany, 2015-09-23 10:34 (3926 d 19:30 ago) – Posting: # 15455
Views: 19,281

Dear Shuanghe,

❝ There's another guidance of rivaroxaban which takes the same approach as dabigatran.


THX for this information. So it seems it is worth the efforts to implement this BE approach in PowerTOST.

Regards,

Detlew

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
151 visitors (0 registered, 151 guests [including 45 identified bots]).
Forum time: 06:04 CEST (Europe/Vienna)

Scientists often have a naïve faith that
if only they could discover enough facts about a problem,
these facts would somehow arrange themselves
in a compelling and true solution.    Theodosius Dobzhansky

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5